IBEX (IBEX) Total Liabilities : $163.6 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is IBEX Total Liabilities?

IBEX's Total Liabilities for the quarter that ended in Dec. 2024 was $163.6 Mil.

IBEX's quarterly Total Liabilities increased from Jun. 2024 ($128.11 Mil) to Sep. 2024 ($135.18 Mil) and increased from Sep. 2024 ($135.18 Mil) to Dec. 2024 ($163.56 Mil).

IBEX's annual Total Liabilities declined from Jun. 2022 ($180.72 Mil) to Jun. 2023 ($143.36 Mil) and declined from Jun. 2023 ($143.36 Mil) to Jun. 2024 ($128.11 Mil).

IBEX Total Liabilities Historical Data

The historical data trend for IBEX's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IBEX Total Liabilities Chart

IBEX Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Liabilities

Get a 7-Day Free Trial

179.09

193.63

180.72

143.36

128.11

IBEX Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															142.06	130.27	128.11	135.18	163.56

IBEX Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

IBEX's Total Liabilities for the fiscal year that ended in Jun. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	70.996	+	(54.308	+	1.673
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	1.128	+	0	+	0)
	=	128.1

Total Liabilities	=	Total Assets (A: Jun. 2024 )	-	Total Equity (A: Jun. 2024 )
	=	293.904	-	165.799
	=	128.1

IBEX's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	110.642	+	(48.981	+	2.819
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	1.119	+	0	+	0)
	=	163.6

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	272.498	-	108.937
	=	163.6

IBEX Total Liabilities Related Terms

Thank you for viewing the detailed overview of IBEX's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

IBEX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » IBEX Ltd (NAS:IBEX) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

IB7:Germany

Address

1717 Pennsylvania Avenue NW, Suite 825, Washington DC, WA, USA, 20006

Website

https://www.ibex.co

IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.

Executives

Robert Thomas Dechant	director, officer: Chief Executive Officer	350 CAMPUS DRIVE, MARLBOROUGH MA 01752
Mohammedulla Khaishgi	director	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Paul Joseph Inson	officer: Chief People Officer	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Julie K Casteel	officer: Chief Sales/Marketing Officer	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Christina Alice Trofimuk-o'connor	officer: Chief Legal Officer	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Bruce Neil Dawson	officer: Chief Sales and CS Officer	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Shuja Keen	director	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Pinebridge Gem Ii G.p., L.p.	director, 10 percent owner	65 E. 55TH STREET, NEW YORK NY 10022
Gerard J Kleisterlee	director	ONE DELL WAY, ROUND ROCK TX 78682
Resource Group International Ltd	director, 10 percent owner	CRAWFORD HOUSE,, 50 CEDAR AVENUE, HAMILTON D0 HM 11
Jeffrey Hays Cox	officer: President of IBEX Digital	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
James Dominic Ferrato	officer: Chief Information Officer	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Taylor C Greenwald	officer: Chief Financial Officer	C/O SYNCHRONOSS TECHNOLOGIES, INC., 200 CROSSING BOULEVARD, 3RD FLOOR, BRIDGEWATER NJ 08807
Michael Joseph Darwal	officer: Interim CFO and EVP, IR	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006
Daniella Ballou-aares	director	1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON DC 20006